Cell Culture Dish Podcast

By Brandy Sargent

The Cell Culture Dish (CCD) podcast covers areas important to the research, discovery, development, and manufacture of disease and biologic therapeutics. Key industry coverage areas include: drug discovery and development, stem cell research, cell and gene therapy, recombinant antibodies, vaccines, and emerging therapeutic modalities.

  1. 1.
    Integrated Freezing Solutions to Minimize Risk and Preserve Product Quality
    10:11
  2. 2.
    Enabling process development for continuous bioprocessing: Answering the call for small scale tools that are fit for purpose
    32:38
  3. 3.
    The CHO Cell Line – From Reliable Workhorse to State-of-the-art Protein Powerhouse
    29:31
  4. 4.
    The Secret Ingredient in Your Gene Therapy Success Recipe
    19:53
  5. 5.
    3D cell culture bioreactor system for growing and maintaining spheroids and organoids with the structure and function of in vivo cells
    22:22
  6. 6.
    Applications and Impact of CRISPR/CAS9 in Bioprocessing
    20:22
  7. 7.
    Optimizing Protein Expression and Purification using Mass Spectrometry Analysis
    31:23
  8. 8.
    New Lab Set Up – Best Practices for a Successful Start
    26:07
  1. 9.
    Demystifying the FBS Selection Process – A guide for evaluating product quality, origination and cost consideration
    18:32
  2. 10.
    Reducing Fill Risk in Drug Product Manufacture Utilizing New State-of-the-Art Systems and Platforms
    17:49
  3. 11.
    The Challenge of Staying Current with Regulatory Changes – How one company is providing a solution
    10:36
  4. 12.
    Computer Aided Biology Platform Helps Companies Meet the Challenges of 21st Century Biomanufacturing
    26:19
  5. 13.
    Balancing Risk, Cost and Speed During Clinical Development While Still Maintaining Quality
    11:27
  6. 14.
    Solving the challenges of standardizing cell counting to ensure reproducibility in experiments, assays and manufacturing processes
    17:06
  7. 15.
    A Look Towards the Future of 3D Cell Culture – A panel discussion
    20:13
  8. 16.
    Multistem – A Stable, Off-the Shelf Regenerative Medicine Has Demonstrated Promise in Treating Patients with Acute Respiratory Distress Syndrome or ARDS
    32:43
  9. 17.
    Bi-Specific Antibodies – The development, manufacture and promise of these cutting-edge therapeutics
    32:50
  10. 18.
    Rapid At-line Media Analyzer Speeds Process Development by Eliminating Analytics Bottleneck
    16:49
  11. 19.
    Non-Animal Origin cell culture supplements and manufacturing aids for biologics manufacturing
    22:11
  12. 20.
    Mesenchymal Stem Cell Culture – Challenges and solutions for isolation, expansion and maintenance
    18:58
  13. 21.
    CryoVault Freeze and Thaw Platform Provides a Scalable, Robust and Single-Use End-to-End Solution for Bulk Drug Substance
    26:39
  14. 22.
    Generating actionable data and analysis in complex models using live-cell analysis
    14:37
  15. 23.
    Improved gene therapy analytics permit monitoring of critical quality attributes and increased manufacturing efficiency
    8:57
  16. 24.
    New Advancements in Cell and Gene Therapy Implementing Precision Medicine
    30:48
  17. 25.
    Live Cell Analysis for Neuroscience Research
    11:49
  18. 26.
    Using 3D cell-based human liver microtissue models in predicting adverse effects caused by chronic exposure to engineered nanomaterial
    16:28
  19. 27.
    Raw Material Quality – Identifying and Mitigating Variation
    17:30
  20. 28.
    Antibody Drug Conjugate (ADC) Development and Manufacturing Challenges and Solutions
    16:57
  21. 29.
    Mustang Bio’s gene therapy has tremendous potential to cure XSCID or Bubble Boy Disease based on study results from St. Jude
    14:14
  22. 30.
    Successful Methods for Perfusion Process Optimization
    16:33
  23. 31.
    How Live Cell Analysis Technology is Meeting the Needs of Ever Evolving Advanced Cell Models
    16:27
  24. 32.
    Innovative vaccine manufacturing enables the delivery of vaccines to the developing world
    18:01
  25. 33.
    Optimizing Fed Batch Culture – Developing New Tools and Methods to Improve Production
    12:19
  26. 34.
    Using cell culture models of endocrine resistance to improve triple positive breast cancer treatment options.
    19:22
  27. 35.
    Integrating bioprocessing steps to improve efficiency and reduce cost
    8:32
  28. 36.
    Expediting cell and gene therapy workflows
    26:39
  29. 37.
    A Road Map for Efficient Fed-Batch Cell Culture Optimization
    15:31
  30. 38.
    Viral Vector Manufacturing for Gene Therapy
    16:17
  31. 39.
    Key Considerations in Gene Therapy Manufacturing for Commercialization – A panel discussion
    33:30
  32. 40.
    Closed System Cell Therapy Manufacturing – Moving from the lab to clinical and commercial production
    24:04
  33. 41.
    Successful Mesenchymal Stem Cell Manufacturing for Cell Therapy Applications
    29:11
  34. 42.
    Bioprocessing Technologies for Stem Cell Therapy
    8:17
  35. 43.
    Cell Therapy Manufacturing – Opportunities and Challenges
    19:16
  36. 44.
    Novel Technology Enables Encapsulated Cell Therapies Without Triggering Fibrosis
    18:14
  37. 45.
    FBS – It’s Not All Created Equal – What Consumers Need to Know
    14:23
  38. 46.
    Do You Have to Sacrifice Antibody Titer for Quality? Employing cell biology to get the best of both worlds
    22:46
  39. 47.
    Implementation of Single-use Bioreactors for Microbial Fermentation is Easier Than You Think
    18:40
  40. 48.
    Single-use Bioreactors for Fermentation – It’s now a reality that deserves consideration
    12:32
  41. 49.
    Bioengineered Organ Implants Poised to Change Treatment Paradigms in Esophageal Cancer
    16:00
  42. 50.
    Improving lab productivity and reproducibility by taking a fresh look at existing workflows and protocols
    24:19

Listen to Cell Culture Dish Podcast now.

Listen to Cell Culture Dish Podcast in full in the Spotify app